Adhesions are internal scars that damage vital organs.

Emergency Surgery Admissions

400K

Infertility Cases

1M 

6M

Chronic Abdominal Pain Cases

Annual Burden

$5B 

Spending on complications from adhesions

1 in 4

Patients re-admitted

25% of patients who undergo abdominal or pelvic surgeries will be admitted for complications from adhesions

Surgery always causes inflammation of surrounding tissues

Adhesions, or bands of scars, begin to form within 5 days of surgery

How does TYBR Spray work?

Hydrogel

Technology

Proprietary material that reduces adhesions and improves the healing response of tissue.

Laparoscopic Compatible

While >70% of procedures are performed minimally invasively, there are no good options for adhesion prevention. Our material is delivered through a simple and steerable device and is compatible with open and minimally invasive operations. 

Tim Keane, PhD

Tim Keane is bioengineer and regenerative medicine expert. Prior to co-founding TYBR, he was a Post-Doctoral Fellow at Imperial College London where he designed and tested biomaterials to enhance tissue healing following injury. He holds a BSc in Chemical Engineering and PhD in Bioengineering from the University of Pittsburgh. He is co-inventor on 8 filed patents and has authored over 28 peer-reviewed publications garnering 1700+ citations.

Stephen Ramon

Stephen is a bioengineer and M.D. candidate. He graduated with a BSc in Biomedical Engineering from University of Virginia, and is currently completing his final year of medical school. During his time at U.Va, he conducted prototype testing for medical devices, built mechatronic components for orthopedic devices at the Hospital for Special Surgery, and participated in the Darden School of Business Incubator program. 

Alex Smith, PhD

Alex Smith is a mechanical engineer who holds a B.Sc. and M.Eng. in Biomedical Engineering from Texas A&M University and a PhD in Mechanical Engineering from University of Houston and the Texas Heart Institute. He previously created a new ported graft to enable reliable and consistent hemodialysis access for Sceptre Medical. At the Texas Heart Institute, he also designed a minimally invasive partial support left ventricular assist device to treat early-stage heart failure.